Resource • Article
The Rescue Option: Course Correcting Struggling Clinical Trials
The Rescue Option: Course Correcting Struggling Clinical Trials
Choosing to embrace the support of study rescue and recovery reflects strong leadership and a proactive commitment to maintaining the integrity, efficiency, and success of clinical research.
Why is the idea of being “rescued” celebrated in some situations, but met with resistance in others?
Clinical trials are complex endeavors and it’s not uncommon for studies to run into serious problems midcourse. In the past, bringing in a Rescue CRO was seen as a last resort – a hesitant admission that a trial was going off track. However, this perception is rapidly changing. Rescue CROs have emerged as proactive problem-solvers, stepping in when sponsors need them most, to support and/or salvage struggling trials, optimize performance, and maintain regulatory compliance. By intervening at the right time, these specialists can turn a potential obstacle into a success story and ultimately help bring new treatments to market.
Asking for Help
Michael Phelps, the most decorated Olympian of all time, has become a powerful advocate for mental health awareness through his deeply personal advertising campaigns aimed at overcoming the stigma of seeking mental health treatment. In these impactful ads, Phelps openly shares his own struggles with anxiety and depression, emphasizing that even individuals who appear strong and successful can face mental health challenges. By speaking candidly about his journey to recovery and the importance of therapy, Phelps breaks down barriers and normalizes the act of reaching out for help.
Clinical trial sponsors need to take a similar approach to breaking down the stigma of asking for help when a trial gets off track. Just as seeking mental health support is a sign of strength rather than weakness, admitting that a trial needs external expertise should be viewed as a proactive and responsible decision. Trials are complex, and unforeseen challenges such as patient recruitment struggles, data integrity concerns, or regulatory setbacks, can all jeopardize progress. Instead of fearing reputational damage or internal scrutiny, sponsors should embrace collaboration with rescue CROs, consultants, or independent auditors who can offer a fresh perspective with strategic solutions.
Studies have shown that transparency and early intervention improve clinical trial outcomes, reinforcing the importance of an open, solutions-oriented approach.1 By fostering an environment where seeking help is encouraged rather than avoided, sponsors can execute trials remain scientifically rigorous, ethically sound, and ultimately successful in delivering treatments to those who need them most.
When is it… “Time”
Knowing when to ask for help can mean the difference between a salvageable study and a failed one. Implementing an early warning system (EWS) is paramount for identifying and addressing potential issues proactively. A structured escalation process can effectively prevent critical failures and safeguard the integrity of clinical trials.2
The EWS process commences by flagging any deviations or concerns, such as protocol noncompliance or delays in data collection. Subsequently, a comprehensive follow-up analysis is conducted to assess the severity of the issue and determine whether corrective action is feasible within the established framework. Should the problem persist, it is then escalated to leadership, regulatory teams, or external experts to maintain the trial’s continued adherence to the established protocols.
The Power of a Fresh Perspective
Throughout history, a second set of eyes has been instrumental in refining and validating groundbreaking innovations. Jonas Salk’s 1955 polio vaccine is a prime example. While Salk’s initial work showed promise, it was only through the rigorous testing by independent researchers that its safety and efficacy were confirmed, paving the way for widespread use.3 Peer review not only identified potential flaws but also fostered public trust in the vaccine.
Similarly, CRO’s with expertise in study rescue services play a vital role in driving the success of clinical trials. More than “Rescue CROs,” these organizations provide critical oversight when trials face delays, data integrity concerns, or regulatory setbacks.4 Just as peer review was crucial to the success of the polio vaccine, proactively identifying and addressing challenges early helps build trust and keeps studies on track. Acting as that essential second set of eyes, CROs can reassess protocols, validate data, and implement corrective strategies to uphold the highest standards of safety and efficacy.5
It’s a Matter of Trust
Trust is the cornerstone of every successful collaboration, and nowhere is this more critical than in clinical trials. Trust must exist at all levels: sponsors rely on CROs to execute studies effectively, while CROs depend on sponsors to provide the necessary resources. Maintaining this trust requires a thorough balance of communication, transparency, and a shared commitment to the trial’s success.
However, it is when a trial encounters an obstacle, that trust is truly put to the test. Any wariness in exposing issues can prevent teams from seeking the assistance they truly need. But what if asking for help wasn’t seen as a failure, but rather as a demonstration of responsible leadership and an unwavering commitment to success? Imagine a scientific culture where the addition of a second set of eyes did not cause panic or fear but instead provided trial-saving critical insight or validating reassurance.
Research has shown that early intervention and collaboration with external experts can significantly improve trial outcomes and mitigate risks associated with delays or data integrity issues.6 By fostering a culture where seeking expert guidance is viewed as a proactive measure rather than a last resort, stakeholders can strengthen trust, maintain trial integrity, and ultimately bring life-changing treatments to patients more efficiently. Nonetheless, too often, sponsors hesitate to engage a rescue CRO due to concerns over reputational damage, loss of control, or internal scrutiny.
A well-structured rescue strategy is not about dismantling what has already been built – it is about reinforcing and enhancing what already exists. A rescue CRO can work alongside existing teams to build a seamless, constructive path forward, rather than a disruptive overhaul. And coming in fresh, allows the rescue team the ability to objectively analyze trial challenges, identify solutions and suggest a corrective and strategic path forward – recommendations that can strengthen a trial, not undermined it.
Transparency and trust-based partnerships have been proven to enhance trial outcomes. Cultivating an open and collaborative culture in clinical research, will result in stronger and more resilient trials. When trial sponsors and CROs perceive external support as a collaborative partnership rather than a threat, studies recover more swiftly, adhere to regulatory compliance, and ultimately deliver more efficient problem-solving and higher trial completion rates.7
No Time for Delays
Another area of concern in the pharmaceutical industry, impacting both the timely delivery of new treatments to patients and the financial health of sponsoring organizations, is the prevalence of clinical trial delays. These delays can arise from a variety of factors, including patient recruitment challenges, where studies struggle to enroll enough participants, regulatory hurdles, such as prolonged approval processes or compliance issues, and operational inefficiencies, including site management problems or logistical setbacks.
As a result, these obstacles not only extend the development timeline of potentially lifesaving therapies — delaying critical treatments for patients in need — but may also inflict significant financial losses on sponsoring pharmaceutical companies. The longer a trial is delayed, the more costly it becomes, as companies must continue funding research, site maintenance, and regulatory compliance efforts while generating zero revenue from the anticipated treatment. In an industry where speed and efficiency are essential to maintaining competitive advantage and meeting urgent medical needs, minimizing delays is crucial to realizing both financial sustainability and the successful introduction of innovative therapies to the market.
Aspect | Details |
High Incidence of Delays | Approximately 85% of clinical trials experience delays, with 94% of these delayed by over a month. |
Recruitment Challenges | Around 80% of clinical trials are delayed or closed due to issues with patient recruitment, with 37% of sites under-enrolling and 11% unable to enroll a single patient. |
Cost Per Day | Each day a clinical trial is delayed can result in approximately $500,000 to $8 million in lost revenue, depending on the drug and market. |
- Daily Operational Costs: The direct cost of conducting a clinical trial is about $40,000 per day, with Phase III trials costing up to $55,716 per day.
- Patient Recruitment Expenses: Recruitment challenges are a major contributor to delays, with patient recruitment accounting for nearly 40% of the U.S. pharmaceutical research budget, totaling around $1.89 billion annually.
By stepping in to assess and address trial deficiencies, Rescue CROs can implement corrective measures that salvage failing studies, restore compliance, and optimize trial execution.
Turning the Page
In his inaugural address on March 4, 1933, US President Franklin D. Roosevelt (FDR) unveiled his comprehensive plan to address the economic crisis of The Great Depression. In this speech, FDR declared that the US economy was in a state of emergency, demanding immediate and decisive intervention. He presented a plan he simply called: The Three R’s: Relief, Recovery, and Reform.8
Relief prioritized providing urgent assistance to those in need, Recovery aimed to restore economic stability, and Reform sought to implement safeguards to prevent such a collapse from occurring again. This structured approach normalized and eased citizens fear and thus enabled the nation to emerge from economic turmoil, stronger and more resilient than ever before. This same strategy and mindset should be used to diffuse the hesitancy felt when calling upon a Rescue CRO.
Rescue CROs serve as the emergency responders for clinical trials. Applying the same three basic principles to revive struggling studies, these CROs:
- Provide immediate Relief by addressing recruitment challenges and obstacles.
- Recover operational efficiency and re-engage stakeholders, putting the trial back on track.
- Drive Reform by strengthening compliance, improving trial designs, and implementing innovative approaches to prevent future issues.
Reframing the Argument: Thinking in terms of Recovery
In the complex and fast-paced world of clinical research, even the most meticulously planned studies can encounter unforeseen challenges. Clinical trials often face situations that put timelines, budgets, and outcomes at risk.9 This is precisely where a CRO focused on rescue and recovery can play a pivotal role. These CROs should be thought of as a strategic partner, one that specializes in intervening when clinical trials are in danger of missing milestones and short/long-term goals.
The Rescue/Recovery CRO’s expertise lies in swiftly identifying issues and implementing tailored strategies to realign the study with its objectives. This may involve revising trial protocols, enhancing participant recruitment, sustaining regulatory compliance, and improving data collection. The Rescue/Recovery CRO understands that the primary goal is to safeguard the investment in the trial and review the reliability of its results.10
Benefit | Details |
Enhanced Problem-Solving | Utilizing their specialized expertise to navigate complex trial challenges |
Improved Efficiency | Streamlining operations to reduce delays and optimize resource utilization |
Regulatory Expertise | Maintaining compliance with evolving regulations, thereby minimizing potential legal setbacks |
Risk Mitigation | Proactively identifying and addressing risks before they escalate into more significant issues |
Choosing to embrace the support of study rescue and recovery reflects strong leadership and a proactive commitment to maintaining the integrity, efficiency, and success of clinical research. By integrating the services of a Rescue/Recovery CRO into their operational strategy, forward thinking organizations display a willingness to prioritize not just the logistical execution of clinical trials, but also the overarching primary goal of advancing medical science. Taking an approach that includes an allowance for a Rescue/Recovery CRO, transforms setbacks or unforeseen challenges within clinical trials into opportunities for innovation, rapid problem-solving, and continuous improvement, rather than leading to trial stagnation or stoppage.
Observing the Rescue/Recovery CRO through the lens of a Sponsor provides a valuable tool to keep in the clinical trial “toolbox.” This approach is both strategic and practical. Just as a skilled craftsman keeps various specialized tools at hand for specific situations, successful clinical research teams must be prepared to swiftly leverage specialized expertise to navigate complexities and maintain momentum. This mindset fosters resilience, confirming that trials remain on track, ethical standards are upheld, and, most importantly, groundbreaking treatments continue to reach patients without unnecessary delays.
Why Rescue/Recovery CROs Matter
- Saving Trials from Costly Situations
Clinical trials are significant financial investments, often costing millions of dollars. When a trial faces challenges, it can lead to substantial financial losses and delays in delivering new treatments to patients. Rescue/Recovery CROs specialize in swiftly identifying and addressing issues to realign the study with its objectives, thereby preventing the need for a complete restart to the trial or termination.11
- Expertise in Crisis Management
Rescue/Recovery CROs are adept at managing complex problems that may arise during clinical trials, such as recruitment difficulties, site compliance issues, data integrity concerns, or regulatory hurdles. Their experienced teams conduct rapid assessments and interventions to minimize disruptions and drive the trial forward effectively.12
- Regulatory Navigation and Compliance
Navigating regulatory challenges is another common reason for engaging a Rescue/Recovery CRO. These organizations possess regulatory expertise, experience in handling audits, and established relationships with regulatory agencies. This enables them to develop solutions that meet compliance requirements while preserving the integrity of the trial.13
- Strengthening Sponsor Confidence and Stakeholder Trust
Encountering issues during a trial can undermine the confidence of sponsors and stakeholders. Engaging a Rescue/Recovery CRO for a support role or a full transition demonstrates a proactive commitment to resolving problems and upholding scientific and ethical standards, thereby restoring trust and confidence in the trial’s success.14
- Efficient and Agile Study Execution
Rescue/Recovery CROs excel in optimizing study performance under tight timelines and high-pressure conditions. They enhance site performance, implement strategic recruitment plans, and utilize advanced technologies to streamline data collection and management, leading to improved efficiency and expedited study timelines.15
The substantial financial burdens of clinical trials emphasize the necessity of strategic planning, robust study design, and early problem identification. By implementing adaptive trial designs, leveraging biomarkers, and fostering collaboration, sponsors can proactively mitigate risks and enhance efficiency in bringing new therapies to market, and having the support of a Rescue/Recovery CRO can play an indispensable role in this process, so that promising treatments do not falter due to operational setbacks.
Partners in Progress
Ultimately, embracing Rescue/Recovery CROs underscores an organization’s dedication to patient well-being, scientific excellence, and the relentless pursuit of innovative therapies. The willingness to seek expert support when trials face critical challenges is not a sign of weakness, but a demonstration of accountability and commitment to excellence. By integrating strategic partnerships with Rescue CROs, organizations foster a culture that values agility, preparedness, and an unwavering commitment to advancing global health outcomes.
